Upregulation of ADAMDEC1 correlates with tumor progression and predicts poor prognosis in non‐small cell lung cancer (NSCLC) via the PI3K/AKT pathway.

Autor: Zhu, Weiliang1 (AUTHOR), Shi, Lin2 (AUTHOR), Gong, Yuxin2 (AUTHOR), Zhuo, Lin2 (AUTHOR), Wang, Siyun2 (AUTHOR), Chen, Shaobing2 (AUTHOR), Zhang, Bei3 (AUTHOR) zb6336@126.com, Ke, Bin3 (AUTHOR) kebin@sysucc.org.cn
Zdroj: Thoracic Cancer. Apr2022, Vol. 13 Issue 7, p1027-1039. 13p.
Databáze: Academic Search Ultimate
Nepřihlášeným uživatelům se plný text nezobrazuje